The comprehensive Peripheral Intravenous (IV) Catheter Market report delves deep into product specifications, technology insights, production analysis, and more, assessing crucial elements like revenue, costs, and margins. It sheds light on the dynamic actions of industry leaders—ranging from developments to mergers—and conducts a competitive analysis within the vibrant Chemical and Materials sector. This report not only evaluates historical data but also offers insights into the current market performance, presenting a professional and meticulous analysis of the industry's present landscape.

With a thorough exploration of product details, technological advancements, and production analysis, the Peripheral Intravenous (IV) Catheter Market report delves into critical aspects like revenue, costs, and margins. Additionally, it scrutinizes market status, growth rates, upcoming trends, driving forces, potential opportunities, challenges, risks, entry barriers, sales channels, and distribution networks using Porter's Five Forces analysis. The transparent and reliable market information contained herein serves as a valuable resource for businesses, enhancing decision-making and optimizing return on investment (ROI). Detailed SWOT analysis provides a comprehensive understanding of market drivers and constraints, further enriching the report's insights.

Global peripheral intravenous (IV) catheter market was valued at USD 1.67 billion in 2021 and is expected to reach USD 2.63 billion by 2029, registering a CAGR of 5.5% during the forecast period of 2022-2029

 

Definition

A peripheral intravenous catheter (PIVC) is a thin flexible tube that is placed into a vein in the arm or leg to deliver medications and nutritional supplements. Blood samples are also collected for diagnostic purposes. Short peripheral intravenous catheters (PIVCs) and integrated/closed catheters are the two types of peripheral intravenous (IV) catheters (PIVCs).

Get a Sample Research Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-peripheral-intravenous-iv-catheter-market

Key Growth Drivers:

  • Growing Requirement Across Healthcare

The increase in prevalence of chronic diseases and rise in population aging are the most significant factors driving the growth for this market. The rise in number of hospitalizations is also expected to accelerate the market's overall growth.

Furthermore, the rise in focus on curtailing needle-stick injuries and high healthcare expenditure are also expected to fuel market growth. Moreover, the high adoption of safety ported short peripheral intravenous catheters also cushions the market’s growth within the forecasted period. The high adoption of these products in emerging economies is also projected to bolster the market's growth.

The report emphasizes the participation of key entities, notably:

  • BD (U.S.)
  • Braun Melsungen AG (German)
  • Smith Medical (U.S.)
  • Terumo Corporation (Japan)
  • Vygon (France)
  • ICU Medical, Inc (U.S.)
  • VOGT Medical (Germany)
  • RenovoRx, Inc (U.S.)
  • Retractable Technologies Inc (U.S.)
  • Nipro (Japan)
  • MedSource Labs (U.S.)
  • Argon Medical Devices, Inc (U.S.)
  • Intra Special Catheters GmbH (Germany)
  • Greiner Bio-One International GmbH (Austria)
  • Medical Components, Inc (U.S.)
  • Ares Medikal (Turkey)
  • ACE MEDICAL COMPANY (U.S.),
  • Merit Medical Systems (U.S.)
  • Heka s.r.l, (Italy)
  • RAUMEDIC AG (Germany)
  • Teleflex Incorporated (U.S.)

Key Market Perspectives:

  • Thorough examination of prevailing market tendencies
  • Updates on the latest product advancements and innovations
  • Peripheral Intravenous (IV) Catheter market's Compound Annual Growth Rate (CAGR) for both historic and forecasted years
  • Strategies and activities of prominent players and brands in the field
  • Insights into the industry landscape for emerging participants

Gain Additional Insight from This Premium Research Report @ https://www.databridgemarketresearch.com/reports/global-peripheral-intravenous-iv-catheter-market 

Key Market Segmentation

Type (Mice Models, Rat Models), Tumor Type (Respiratory Tumor Models, Urological Tumor Models, Gastrointestinal Tumor Models, Hematological Tumor Models, Gynecological Tumor Models, Others), Application (Preclinical Drug Development and Oncology Research, Biomarker Analysis), End User (Contract Research Organization, Academic and Research Institutions, Pharmaceutical and Biotechnology Companies)

Browse More Reports:

https://www.databridgemarketresearch.com/reports/global-oncology-clinical-trial-monitor-market 

https://www.databridgemarketresearch.com/reports/global-erectile-dysfunction-drugs-market 

https://www.databridgemarketresearch.com/reports/global-surgical-tubing-market 

https://www.databridgemarketresearch.com/reports/global-skin-and-wound-disinfection-market 

https://www.databridgemarketresearch.com/reports/global-implantable-infusion-pumps-market 

About Data Bridge Market Research, Private Ltd

Data Bridge Market Research operates as a multinational management-consulting firm, boasting offices situated in both India and Canada. Renowned for our innovative and cutting-edge market analysis methodologies, we pride ourselves on our unparalleled durability and forward-thinking approaches. Our commitment lies in unravelling optimal consumer prospects and nurturing invaluable insights to empower your company's success within the market.

With a team comprising over 500 analysts specializing in various industries, we have been instrumental in serving over 40% of Fortune 500 companies on a global scale. Our extensive network boasts a clientele exceeding 5000+, spanning across the globe. At Data Bridge Market Research, our goal remains steadfast: to provide comprehensive market intelligence and strategic guidance to propel your business toward success.

Contact Us

US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475


Email – corporatesales@databridgemarketresearch.com